Is USINA PHARM still active?

Yes, USINA PHARM is currently active.

Where is USINA PHARM registered?

USINA PHARM's registered address is Rue des Carrières(HAV) 15, 7041 Quévy, Belgium.

How many employees does USINA PHARM have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), USINA PHARM reported 1.3 full-time equivalent employees.

Did USINA PHARM make a profit or a loss?

USINA PHARM's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €349,643.

When did USINA PHARM last file annual accounts?

USINA PHARM's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is USINA PHARM B Corp certified?

We have no B Corp certification on file for USINA PHARM.

Does USINA PHARM hold Fairtrade certification?

No, USINA PHARM does not currently hold Fairtrade certification.

USINA PHARM

Q: When was USINA PHARM founded?

USINA PHARM was founded on 20 Jun 2014, making it 12 years old.

Q: What does USINA PHARM do?

USINA PHARM's registered main activities are Machining of metals, Manufacture of electric lighting equipment, Manufacture of office and shop furniture, Manufacture of moulds and models, and Manufacture of other furniture n.e.c..

BE 0553.961.456

Copied!

BV/SRL

Status

Active

Founded

20 Jun 2014

Size

Small · 1.3 FTE

Age

12 yrs

Main activity

Machining of metals

Certifications & highlights

1 certification

Activities

5 activities

Machining of metalsManufacture of electric lighting equipmentManufacture of office and shop furnitureManufacture of moulds and modelsManufacture of other furniture n.e.c.

Financials

Profit / Loss2025

€350K+45.4%

Equity2025

€2M+27.1%

Cash2025

€790K-25%

2025	2024	2023	2022
€349,643+45.4%	€240,555-16.8%	€289,130-8.4%	€315,555
€2,013,688+27.1%	€1,584,627+17.8%	€1,344,697+5.3%	€1,277,206
€1,205,796-12.9%	€1,384,344-9.1%	€1,522,666-11.8%	€1,726,111
€789,789-25%	€1,053,007+48.7%	€708,273-14.3%	€826,362
1.3-45.8%	2.40%	2.4+20%	2

Frequently asked questions

01What is USINA PHARM's official registered name?

USINA PHARM.

02What is USINA PHARM's enterprise number (VAT number)?

BE 0553.961.456.

03What is USINA PHARM's legal form?

Besloten Vennootschap (BV) / Société à responsabilité limitée (SRL).

04When was USINA PHARM founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Kiwa — Certificate finder

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2023	2022
Income statement
	1.3-45.8%	2.40%	2.4+20%	2
	€783,452+9.8%	€713,847-7.6%	€772,239+19.8%	€644,741
	€80,163-38.4%	€130,056+6.5%	€122,156+33.3%	€91,633
	€16,883-50.7%	€34,221-52.5%	€72,025-91.2%	€818,062
	€491,879+34.5%	€365,854-15.1%	€430,805+13.9%	€378,091
	€349,643+45.4%	€240,555-16.8%	€289,130-8.4%	€315,555
	€145,062+11.6%	€130,011+71%	€76,024+94.4%	€39,111
Profitability
	17.4%+14.4%	15.2%-29.4%	21.5%-13%	24.7%
	10.9%+34%	8.1%-19.6%	10.1%-4%	10.5%
Solvency
	€3,219,484+8.4%	€2,968,971+3.5%	€2,867,363-4.5%	€3,003,317
	€1,376,278-11.9%	€1,562,685-9.8%	€1,733,272-6.9%	€1,862,482
	€1300%	€1300%	€1300%	€130
	€2,013,688+27.1%	€1,584,627+17.8%	€1,344,697+5.3%	€1,277,206
	62.5%+17.2%	53.4%+13.8%	46.9%+10.3%	42.5%
	€656,586-14.6%	€768,665-12.6%	€879,281-4%	€916,066
	0.33-32.8%	0.49-25.8%	0.65-8.8%	0.72
	€1,205,796-12.9%	€1,384,344-9.1%	€1,522,666-11.8%	€1,726,111
	0.60-31.5%	0.87-22.8%	1.13-16.2%	1.35
Liquidity
	€789,789-25%	€1,053,007+48.7%	€708,273-14.3%	€826,362
	€439,289+30.2%	€337,409-9.6%	€373,063+51.1%	€246,844
	€47,623-55.4%	€106,805-36.1%	€167,055-64.8%	€474,839
	€546,397-10.8%	€612,746-2.7%	€629,888-21.9%	€806,572
	1.91+243.1%	0.56-11.7%	0.63+82.9%	0.34
	€1,287,580+65.2%	€779,389+65.9%	€469,686+59.2%	€294,968
Profit appropriation
	—	—	€218,462+54.5%	€141,370
	€1,914,875+22.3%	€1,565,232+18.2%	€1,324,677+5.6%	€1,254,009

Sources

NBB — Nationale Bank van België

USINA PHARM

Certifications & highlights

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements